From Obscurity to Opportunity: LpxH Emerges as a Promising Antibiotic Target in the Battle against Gram-Negative Pathogens
Abstract
The surging crisis of multidrug-resistant Gram-negative pathogens underscores the urgent need for antibiotics with novel mechanisms of action. A promising strategy is to target previously unexploited pathways, such as lipid A biosynthesis. Lipid A functions as the membrane anchor of lipopolysaccharide and constitutes the outer monolayer of the outer membrane of Gram-negative bacteria. LpxH, a Mn2+-dependent phosphoesterase, catalyzes the conversion of UDP-2,3-diacylglucosamine to lipid X, a key precursor in lipid A production. Disruption of this essential step compromises outer membrane integrity, leading to bacterial death, making LpxH an attractive antibiotic target. Since AstraZeneca's discovery of the first small-molecule LpxH inhibitor a decade ago, research has progressed substantially. The development of nonradioactive LpxH activity assays has enabled rapid screening and characterization of inhibitors. Structural and biochemical studies have revealed the architecture of LpxH and dynamic properties of the bound inhibitors, informing structure- and dynamics-based inhibitor design. Notably, recent breakthroughs from academic institutions and pharmaceutical companies have produced LpxH inhibitors with potent antibacterial activity against wild-type Enterobacterales in both in vitro and in vivo models. This review describes the biological role of LpxH and its paralogs, highlights recent advances in assay development and structural analysis, and surveys the current…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.